Interview by Jonathan Kersting
Opioid overdose is the #1 killer of Americans under 50. Roughly half of the 80,000 deaths per year occur in isolation, with no chance for a bystander to administer the lifesaving drug naloxone.
Resilient Lifescience is developing a solution: a wearable medical device with potential to automatically detect and reverse an opioid overdose.
CoFounder and CEO Brad Holden tells us how Resilient Lifescience is trying to tackle the problem and why the company is in Pittsburgh to do it.